S2 Ep1: MGD-Associated Dry Eye Disease – How Emerging Options May Shift The Treatment Paradigm PER Spectives podcast

Artwork

Science Biology Podcasting Education Medicine Spectives

Indhold leveret af PER Spectives and PER® Spectives. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af PER Spectives and PER® Spectives eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

PER Spectives « »
S2 Ep1: MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm

2y ago 18:42

Del

MP3•Episode hjem

Indhold leveret af PER Spectives and PER® Spectives. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af PER Spectives and PER® Spectives eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the underlying pathophysiology of the disease are lacking. Emerging agents with novel mechanisms for treating MGD may ultimately provide new treatment alternatives.
This podcast episode provides a review of some of the key highlights from a live symposium held during the American Academy of Optometry Annual Meeting 2022 in October.
Faculty
Kelly K. Nichols, OD, MPH, PhD, FAAO
Dean
University of Alabama at Birmingham School of Optometry
Birmingham, AL
Marc R. Bloomenstein, OD, FAAO
Director, Optometric Services
Schwartz Laser Eye Center
Scottsdale, AZ

… continue reading

29 episoder

#Science #Biology #Podcasting Education #Medicine #Spectives

Artwork

S2 Ep1: MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm

published 2y ago

Del

MP3•Episode hjem

Indhold leveret af PER Spectives and PER® Spectives. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af PER Spectives and PER® Spectives eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the underlying pathophysiology of the disease are lacking. Emerging agents with novel mechanisms for treating MGD may ultimately provide new treatment alternatives.
This podcast episode provides a review of some of the key highlights from a live symposium held during the American Academy of Optometry Annual Meeting 2022 in October.
Faculty
Kelly K. Nichols, OD, MPH, PhD, FAAO
Dean
University of Alabama at Birmingham School of Optometry
Birmingham, AL
Marc R. Bloomenstein, OD, FAAO
Director, Optometric Services
Schwartz Laser Eye Center
Scottsdale, AZ

… continue reading

29 episoder

#Science #Biology #Podcasting Education #Medicine #Spectives

Todos los episodios

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner